Edwards Lifesciences Reports Second Quarter Results
Business Wire•23/07/2026•16:15 ET
0
Whiz Insights
Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended June 30, 2026.
Q2 sales grew 13.6% to $1.74 billion(1), constant currency(2) sales grew 12.5%
Get started
Create a free account to read the full story.